NewsBenzingaCoherus BioSciences 第三季度调整后每股收益为 $(0.20),好于 $(0.22) 的预期;销售额为 1,427.4 万美元,低于 1,600.5 万美元的预期 Coherus BioSciences 第三季度调整后每股收益为 $(0.20),好于 $(0.22) 的预期;销售额为 1,427.4 万美元,低于 1,600.5 万美元的预期 Benzinga 2026.11.09 21:14 (GMT+0) Open on Benzinga Other news Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’ Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know ‘The Noise Will Work Itself Out in Time’: AMD CEO Lisa Su Says Nvidia a ‘Phenomenal Company’ After Jensen Huang Exits Morning Bid: Jensen Huang's last hurrah, and a nervy future for Nvidia
Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’
‘The Noise Will Work Itself Out in Time’: AMD CEO Lisa Su Says Nvidia a ‘Phenomenal Company’ After Jensen Huang Exits